Sponsor:
Carle Foundation Hospital
Code:
NCT02334293
Conditions
Cholestasis
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Not accepted
Interventions
Omegaven
Brief summary:
Conditions
Cholestasis
Study ID
NCT02334293
Start date
Oct, 2013
Status verified date
Jan, 2015
Primary completion date
Jul, 2017
Anticipated
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Not accepted
Enrollment
25 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
other: Omegaven
Interventions
Omegaven
Primary outcome measure
Central contacts
Locations
Carle Foundation Hospital
Recruiting
Urbana, Illinois, United States, 61801
Contacts
Principal Investigator:
William Stratton, MD
Sponsor
Carle Foundation Hospital
Last update posted
Jan 8, 2015
Last verified
Jan, 2015
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Carle Foundation Hospital on 2015-01-08.